Fact CheckerSign in

NCT07679165Completed

The Impact of Symptom Management Nursing Intervention on the QoL of Patients With Advanced Lung Cancer: Mediation of Self-management Efficacy and Regulation of Psychological Resilience

Dahua Hospital, Xuhui District, Shanghai

Source: ClinicalTrials.gov · Last updated 1 Jul 2026

Brief summary (registry, in English)

Symptom management nursing intervention can improve the self-management efficacy, psychological resilience, and QoL of patients with advanced lung cancer.

Status (registry)
Completed
Study type
Interventional
Enrollment
176 (actual)
First submitted
25 Jun 2026
Start date
10 Jun 2023
Primary completion date
27 Oct 2024
Lead sponsor
Jie Zeng
Diseases
Lung cancer
NCT number
NCT07679165

What you commit to

  • Study type: Interventional
  • Participants enrolled: 176
  • From 10 Jun 2023 to the primary completion date, 27 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • primary malignant tumors in other parts
  • history of severe heart, liver, kidney and other important organ failure, severe infection or mental illness
  • Unable to cooperate with the study due to cognitive impairment, visual and hearing impairment

Other

  • participating in other similar nursing intervention studies.

Who the study is looking for

  • According to the diagnostic criteria of primary lung cancer \[9\], the clinical stage was stage ⅢB-Ⅳ
  • aged 18-75 years old
  • Karnofsky performance status (KPS) ≥60 and expected survival ≥3 months
  • Patients had clear consciousness and normal cognitive function, and could complete the questionnaire independently or with the assistance of the researcher
  • have basic communication skills and can cooperate to complete the whole intervention
  • Patients or their families informed and signed the consent form.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dahua Hospital, Xuhui District, Shanghai
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.